The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on May 26, 2026

Une Nouvelle Enquête Révèle qu'les Innovations dans  la Nicotine Sont Associées à un Meilleur Bien-être des Ménages
Ellipse and Entrust Secure Agentic Commerce with EVC Dynamic Card Security Code
New novelty now available in the SNS campaign for the TV Anime 'Attack on Titan' × Nijigen no Mori collaboration event
MultiHopper Opens API for AI Agents Seeking Compliant, Private Onchain Programmable Payment Infrastructure
Naqi Logix Joins Lenovo Innovation Accelerator at BEYOND Expo at Macao
As Monsoon Arrives, Madhya Pradesh Highlights the Season's Key Destinations and Events
Lux Travel DMC Introduit Ses Circuits De Luxe De Deux Semaines Au Vietnam
NANOBIOTIX Announces Closing of Global Offering
Pasqal and Bleichroeder Acquisition Corp. II Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
Inventiva Reports 2026 First Quarter Financial Information¹
Inventiva publie ses informations financières du premier trimestre 2026¹
Kairntech accompagne Cairn.info dans le lancement de Cairn SophIA, une IA souveraine pour les SHS
ABL Diagnostics et le CHRU Nancy : premier bilan positif pour le projet PREDAVIR après 6 mois
Markos D1 Arrives to The 79th Cannes film festival
Making the Grade on Convenience: USC Campus Store Adds Pickup with Quadient Smart Parcel Lockers
REMINDER - SOITEC invitation FY26 results - May 28, 2026
Voting Results from Constellium's 2026 Annual General Meeting
Transgene présente des résultats précliniques avec TG-MVA, un nouveau vaccin prophylactique contre la variole du singe (mpox), au Congrès mondial sur les maladies infectieuses
Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases

Share this page:

Sign up for:

The France Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.